Concurrent apatinib and local radiation therapy for advanced esophageal adenocarcinoma.

Liu, G; E, M; Wang, C; He, Y; Yin, H

Liu, G; E, M; Wang, C; He, Y; Yin, H.

Afiliação

Liu G; Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
E M; Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Wang C; Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
He Y; Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Yin H; Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, China.

J Biol Regul Homeost Agents ; 33(4): 1177-1182, 2019.

Article em En | MEDLINE | ID: mdl-31317697

Assuntos

Adenocarcinoma/tratamento farmacológico; Adenocarcinoma/radioterapia; Antineoplásicos/uso terapêutico; Piridinas/uso terapêutico; Humanos

Palavras-chave

apatinib; esophageal adenocarcinoma; molecular targeted therapy; radiation therapy

Buscar no Google

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Adenocarcinoma / Antineoplásicos Limite: Humans Idioma: En Revista: J Biol Regul Homeost Agents Assunto da revista: BIOLOGIA / BIOQUIMICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Itália

Buscar no Google

Adicionar na Minha BVS

Imprimir

XML

PubMed Links